Levels of Catechols in Epileptogenic and Nonepileptogenic Regions of the Human Brain

Journal of Neurochemistry

Volumn 50, Issue 1, 1988, Pages 225-229

  Goldstein, David S ^a   Nadi, N Suzan ^b   Stull, Robin ^a   Wyler, Allen R ^c   Porter, Roger J ^b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

3,4 Dihydroxyphenylalanine; Adrenoceptors; Brain; Catecholamines; Dopamine; Epilepsy; Norepinephrine; Seizures; Tyrosine hydroxylase

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; CATECHOLAMINE; DOPA; DOPAMINE; NORADRENALIN; TYROSINE 3 MONOOXYGENASE;

BRAIN; CLINICAL ARTICLE; EPILEPSY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SEIZURE;

ADULT; BRAIN; DIHYDROXYPHENYLALANINE; DOPAMINE; EPILEPSIES, PARTIAL; EPINEPHRINE; HUMAN; METHOXYHYDROXYPHENYLGLYCOL; MIDDLE AGE; NOREPINEPHRINE;

EID: 0023830720     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.1988.tb13253.x     Document Type: Article

References (26)

1. Changes in the brain catecholamines in patients with dementia of Alzheimer type
2. Treatment of two hundred disturbed psychotics with reserpine
3. Alpha‐1 adrenoceptors are decreased in human epileptic foci
4. 3H]dihydroalprenolol
5. Long‐term effects of MPTP on central and peripheral catecholamine and indoleamine concentrations in monkeys
6. Simultaneous liquid chromatographic determination of 3,4‐dihydroxypbenylgly‐col, catecholamines, and 3,4‐dihydroxyphenylalanine in plasma and their responses to inhibition of monoamine oxidase
7. Activation of tyrosine hydroxylase in the frontal cortex by phentolamine and prazosin
8. Simultaneous measurement of DOPA, DOPAC, and catecholamines in plasma by liquid chromatography with electrochemical detection
9. Catecholamine levels in the epileptic focus and cerebrospinal fluid of epileptics
10. Differential effect of benserazide on catecholamine concentrations in the rat pineal, cerebral cortex and hypothalamus
11. Cloni‐dine effects on catecholamine levels and turnover in discrete hypothalamic and extra‐hypothalamic areas
12. Neurotransmitter abnormalities as determinants of seizure predisposition in the genetically epilepsy‐prone rat,
13. Neurotransmitter abnormalities in genetically epileptic rodents
14. Rat brain norepinephrine metabolism: substantial clearance through 3,4‐di‐hydroxyphenylethyleneglycol formation
15. Protein measurement with the Folin phenol reagent
16. Depletion of noradrenaline and amygdaloid kindling
17. Effects of piperine on convulsions and on brain serotonin and catecholamine levels in El mice
18. Modulatory role for biogenic amines in the cerebral cortex. Microiontophoretic studies
19. Poststimulation catecholamine synthesis and tyrosine hydroxylase activation in central noradrenergic neurons. 1. In‐vivo stimulation of the locus coeruleus
20. Amino acid and catecholamine markers of metabolic abnormalities in human focal epilepsy,
21. Enzymatic changes in actively spiking areas of human epileptic cerebral cortex
22. Alterations of noradrenaline and serotonin uptake and metabolism in chronic cobalt‐induced epilepsy in the rat
23. Determination of picomole amounts of dopamine, noradrenaline, 3,4‐di‐hydroxyphenylalanine, 3,4‐dihydroxyphenylacetic acid. homovanillic acid, and 5‐hydroxyphenylacetic acid in nervous tissue after one‐step purification on Sephadex G‐10. using high‐performance liquid chromatography with a novel type of electrochemical detection
24. Effects of drugs interfering with dopamine and noradrenaline biosynthesis on the endogenous 3,4‐dihydroxyphenylalanine levels in rat brain
25. Acute effects of oral or parenteral aspartame on catecholamine metabolism in various regions of rat brain
26. Reduction of biogenic amine levels in the Rett syndrome